SQUINTO STEPHEN P
Insider CIK 1231954 · CMMB Director · BOLD Director · NONE Director · SWTX Director, 10% owner · PASG Head of Research and Dev, Director · ALXN EVP, Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-05-19 | 2022-05-20 | 15,318 | — | $0 | 15,318 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-05-19 | 2022-05-20 | 4,818 | — | $0 | 131,652 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-05-20 | 2021-05-21 | 6,998 | — | $0 | 6,998 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-05-20 | 2021-05-21 | 1,106 | — | $0 | 126,834 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-28 | 2021-04-28 | 19,231 | $76.20 | $1.47M | 125,728 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-27 | 2021-04-28 | 201 | $75.05 | $15.1K | 144,959 | SEC↗ |
| CMMB Chemomab Therapeutics Ltd. | A Award deriv | 2021-04-19 | 2021-04-21 | 23,768 | — | $0 | 23,768 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-15 | 2021-04-19 | 1,057 | $75.01 | $79.3K | 145,160 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2021-04-14 | 2021-04-19 | 511 | $75.08 | $38.4K | 146,217 | SEC↗ |
| NONE Compass Therapeutics, Inc. | A Award deriv | 2020-08-06 | 2020-08-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-05-20 | 2020-05-22 | 7,464 | — | $0 | 7,464 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2020-03-12 | 2020-03-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 185,776 | — | $0 | 185,776 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 33,836 | — | $0 | 33,836 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion deriv | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 6,078,103 | — | $0 | 6,078,103 | SEC↗ |
| SWTX SpringWorks Therapeutics, | C Conversion | 2019-09-17 | 2019-09-19 | 1,053,204 | — | $0 | 7,131,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | P Buy | 2019-09-17 | 2019-09-19 | 275,000 | $18.00 | $4.95M | 7,406,307 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-09-12 | 2019-09-16 | 29,983 | — | $0 | 29,983 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-03-29 | 2019-09-16 | 6,931,142 | — | $0 | 1,053,204 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2019-03-29 | 2019-09-16 | 40,000,000 | — | $0 | 6,078,103 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2017-10-08 | 2017-10-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2016-08-24 | 2016-08-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-27 | 2014-10-28 | 3,075 | $78.88 | $242.6K | 7,737 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-27 | 2014-10-28 | 2,475 | $42.66 | $105.6K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-27 | 2014-10-28 | 2,069 | $189.00 | $391.0K | 106,508 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-27 | 2014-10-28 | 3,841 | $188.36 | $723.5K | 108,577 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-27 | 2014-10-28 | 3,075 | $78.88 | $242.6K | 112,418 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-27 | 2014-10-28 | 2,475 | $42.66 | $105.6K | 109,343 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-03 | 2014-10-07 | 10,025 | $42.66 | $427.7K | 2,475 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-03 | 2014-10-07 | 10,025 | $42.66 | $427.7K | 116,893 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-03 | 2014-10-07 | 5,100 | $169.95 | $866.7K | 111,793 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-03 | 2014-10-07 | 4,925 | $174.95 | $861.6K | 106,868 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-09-24 | 2014-09-26 | 76 | $159.50 | $12.1K | 106,868 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-08-04 | 2014-08-05 | 1,662 | $157.42 | $261.6K | 106,944 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 49,200 | $176.80 | $8.70M | 49,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 4,000 | — | $0 | 108,606 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-10 | 2014-02-10 | 1,635 | $167.31 | $273.6K | 101,308 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 20 | $157.51 | $3.2K | 102,943 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 1,600 | $155.55 | $248.9K | 102,963 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-06 | 2014-02-10 | 3,800 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-06 | 2014-02-10 | 3,800 | $155.11 | $589.4K | 94,818 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-06 | 2014-02-10 | 3,800 | $93.83 | $356.6K | 98,618 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-06 | 2014-02-10 | 9,745 | — | $0 | 104,563 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-04 | 2014-02-05 | 6,250 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-04 | 2014-02-05 | 10,813 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-04 | 2014-02-05 | 7,876 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-02-04 | 2014-02-05 | 3,800 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-04 | 2014-02-05 | 7,876 | $22.90 | $180.4K | 103,592 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-04 | 2014-02-05 | 3,800 | $93.83 | $356.6K | 124,455 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-04 | 2014-02-05 | 10,813 | $78.88 | $852.9K | 120,655 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-02-04 | 2014-02-05 | 6,250 | $42.66 | $266.6K | 109,842 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-04 | 2014-02-05 | 29,637 | $155.00 | $4.59M | 94,818 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-04 | 2014-02-05 | 3,300 | $157.10 | $518.4K | 95,716 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-04 | 2014-02-05 | 3,200 | $153.63 | $491.6K | 99,016 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 852 | $157.14 | $133.9K | 102,216 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 1,100 | $133.31 | $146.6K | 103,086 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 18 | $133.21 | $2.4K | 103,068 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-11-04 | 2013-11-05 | 7,875 | $22.90 | $180.3K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-11-04 | 2013-11-05 | 6,250 | $42.66 | $266.6K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-11-04 | 2013-11-05 | 7,875 | $22.90 | $180.3K | 112,061 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-11-04 | 2013-11-05 | 12,886 | $123.82 | $1.60M | 105,425 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-11-04 | 2013-11-05 | 1,239 | $124.39 | $154.1K | 104,186 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-11-04 | 2013-11-05 | 6,250 | $42.66 | $266.6K | 118,311 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-10-28 | 2013-10-30 | 32,437 | $78.88 | $2.56M | 32,437 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-10-28 | 2013-10-30 | 7,600 | $93.83 | $713.1K | 7,600 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-10-28 | 2013-10-30 | 32,437 | $78.88 | $2.56M | 137,623 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 500 | $124.76 | $62.4K | 105,186 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 39,537 | $124.06 | $4.90M | 105,686 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-10-28 | 2013-10-30 | 7,600 | $93.83 | $713.1K | 145,223 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 1,000 | $123.89 | $123.9K | 104,186 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-09-24 | 2013-09-26 | 304 | $112.54 | $34.2K | 105,186 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-09-13 | 2013-09-17 | 1,000 | $114.37 | $114.4K | 105,490 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-05 | 2013-08-07 | 852 | $116.87 | $99.6K | 106,490 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-08-02 | 2013-08-02 | 6,250 | $42.66 | $266.6K | 37,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-08-02 | 2013-08-02 | 7,875 | $22.90 | $180.3K | 15,751 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-08-02 | 2013-08-02 | 7,875 | $22.90 | $180.3K | 115,217 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-02 | 2013-08-02 | 4,912 | $115.05 | $565.1K | 116,555 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-02 | 2013-08-02 | 2,963 | $116.04 | $343.8K | 113,592 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-02 | 2013-08-02 | 4,858 | $114.95 | $558.4K | 108,734 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-02 | 2013-08-02 | 1,392 | $116.12 | $161.6K | 107,342 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-08-02 | 2013-08-02 | 6,250 | $42.66 | $266.6K | 121,467 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-30 | 2013-08-01 | 1,120 | $110.86 | $124.2K | 107,342 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale deriv | 2013-07-12 | 2013-07-16 | 6,876 | $17.98 | $123.6K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale deriv | 2013-07-12 | 2013-07-16 | 11,124 | $22.90 | $254.7K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-12 | 2013-07-16 | 18,000 | $119.90 | $2.16M | 108,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-12 | 2013-07-16 | 11,124 | $22.90 | $254.7K | 126,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-12 | 2013-07-16 | 6,876 | $17.98 | $123.6K | 115,338 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-07-01 | 2013-07-03 | 7,875 | $22.90 | $180.3K | 11,124 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-07-01 | 2013-07-03 | 36,250 | $42.66 | $1.55M | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-01 | 2013-07-03 | 7,285 | $96.84 | $705.5K | 108,502 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-01 | 2013-07-03 | 36,250 | $42.66 | $1.55M | 144,712 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-01 | 2013-07-03 | 7,875 | $22.90 | $180.3K | 152,587 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-01 | 2013-07-03 | 25,175 | $94.34 | $2.38M | 127,412 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-01 | 2013-07-03 | 11,625 | $95.16 | $1.11M | 115,787 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-01 | 2013-07-03 | 40 | $97.46 | $3.9K | 108,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-04-29 | 2013-05-01 | 20,000 | $42.66 | $853.2K | 30,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-04-29 | 2013-05-01 | 16,499 | $22.90 | $377.8K | 18,999 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-04-29 | 2013-05-01 | 36,299 | $98.96 | $3.59M | 108,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-04-29 | 2013-05-01 | 200 | $99.51 | $19.9K | 108,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-04-29 | 2013-05-01 | 16,499 | $22.90 | $377.8K | 124,961 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-04-29 | 2013-05-01 | 20,000 | $42.66 | $853.2K | 144,961 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-03-08 | 2013-03-12 | 13,750 | $17.98 | $247.2K | 6,876 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-03-08 | 2013-03-12 | 6,250 | $22.90 | $143.1K | 59,124 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-12 | 3,085 | $92.17 | $284.3K | 108,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-12 | 16,915 | $91.21 | $1.54M | 111,547 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-03-08 | 2013-03-12 | 6,250 | $22.90 | $143.1K | 128,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-03-08 | 2013-03-12 | 13,750 | $17.98 | $247.2K | 122,212 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-02-06 | 2013-02-08 | 60,800 | — | $0 | 60,800 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 4,500 | — | $0 | 108,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 52 | $96.49 | $5.0K | 81,925 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 2,520 | $95.66 | $241.1K | 81,977 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 767 | $94.32 | $72.3K | 84,497 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 715 | $94.50 | $67.6K | 85,264 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-31 | 2012-07-31 | 1,015 | $105.01 | $106.6K | 85,979 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 60,626 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 39,374 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 668 | $106.14 | $70.9K | 86,994 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 16,300 | $108.88 | $1.77M | 87,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 38,951 | $107.75 | $4.20M | 103,962 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 19,069 | $106.93 | $2.04M | 142,913 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 25,680 | $105.86 | $2.72M | 161,982 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 60,626 | $22.90 | $1.39M | 187,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 39,374 | $17.98 | $707.9K | 127,036 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-09 | 2012-07-11 | 50,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-09 | 2012-07-11 | 44,100 | $100.34 | $4.42M | 93,562 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-09 | 2012-07-11 | 4,700 | $100.98 | $474.6K | 88,862 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-09 | 2012-07-11 | 1,200 | $101.81 | $122.2K | 87,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-09 | 2012-07-11 | 50,000 | $17.98 | $899.0K | 137,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-06 | 2012-06-08 | 5,664 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-06 | 2012-06-08 | 44,336 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-06-06 | 2012-06-08 | 50,000 | $90.00 | $4.50M | 87,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-06-06 | 2012-06-08 | 50,000 | $17.65 | $882.5K | 137,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-17 | 2012-02-22 | 50,000 | — | $0 | 44,336 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-17 | 2012-02-22 | 5,260 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-17 | 2012-02-22 | 6,779 | $82.03 | $556.1K | 87,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-17 | 2012-02-22 | 48,481 | $81.27 | $3.94M | 94,441 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-17 | 2012-02-22 | 50,000 | $17.65 | $882.5K | 142,922 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-17 | 2012-02-22 | 5,260 | $11.92 | $62.7K | 92,922 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-03 | 2012-02-06 | 86,500 | — | $0 | 86,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 13,000 | — | $0 | 87,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-30 | 2012-01-30 | 3,004 | $74.51 | $223.8K | 74,662 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-27 | 2012-01-30 | 663 | $74.41 | $49.3K | 77,626 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-10 | 2012-01-11 | 562 | $75.00 | $42.1K | 78,289 | SEC↗ |